Lloyds Banking Group’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-2,962
Closed -$527K 521
2014
Q3
$527K Buy
2,962
+1,832
+162% +$304K 0.14% 170
2014
Q2
$191K Sell
1,130
-59,305
-98% -$9.23M 0.05% 270
2014
Q1
$7.5M Sell
60,435
-133
-0.2% -$16.2K 0.07% 242
2013
Q4
$6.73M Buy
60,568
+5,969
+11% +$570K 0.06% 254
2013
Q3
$4.94M Sell
54,599
-19,152
-26% -$1.72M 0.05% 265
2013
Q2
$6.21M Buy
+73,751
New +$7.65M 0.07% 225

Other funds holding AGN

Lloyds Banking Group's AGN Position: Q4 2014 in Review

Lloyds Banking Group sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 2,962 shares — an estimated $527K sold.

Lloyds Banking Group first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $7.5M in Q1 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Lloyds Banking Group reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 2,962 Allergan Inc shares in Q4 2014, an estimated $527K.
  • Lloyds Banking Group first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's Allergan Inc position peaked at $7.5M in Q1 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.